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Abstract
Background: Digital image analysis (DIA) enables better reproducibility of immunohistochemistry (IHC) studies.
Nevertheless, accuracy of the DIA methods needs to be ensured, demanding production of reference data sets. We
have reported on methodology to calibrate DIA for Ki67 IHC in breast cancer tissue based on reference data
obtained by stereology grid count. To produce the reference data more efficiently, we propose digital IHC wizard
generating initial cell marks to be verified by experts.
Methods: Digital images of proliferation marker Ki67 IHC from 158 patients (one tissue microarray spot per patient)
with an invasive ductal carcinoma of the breast were used. Manual data (mD) were obtained by marking Ki67-
positive and negative tumour cells, using a stereological method for 2D object enumeration. DIA was used as an
initial step in stereology grid count to generate the digital data (dD) marks by Aperio Genie and Nuclear
algorithms. The dD were collected into XML files from the DIA markup images and overlaid on the original spots
along with the stereology grid. The expert correction of the dD marks resulted in corrected data (cD). The
percentages of Ki67 positive tumour cells per spot in the mD, dD, and cD sets were compared by single linear
regression analysis. Efficiency of cD production was estimated based on manual editing effort.
Results: The percentage of Ki67-positive tumor cells was in very good agreement in the mD, dD, and cD sets:
regression of cD from dD (R2=0.92) reflects the impact of the expert editing the dD as well as accuracy of the DIA
used; regression of the cD from the mD (R2=0.94) represents the consistency of the DIA-assisted ground truth (cD)
with the manual procedure. Nevertheless, the accuracy of detection of individual tumour cells was much lower: in
average, 18 and 219 marks per spot were edited due to the Genie and Nuclear algorithm errors, respectively. The
DIA-assisted cD production in our experiment saved approximately 2/3 of manual marking.
Conclusions: Digital IHC wizard enabled DIA-assisted stereology to produce reference data in a consistent and
efficient way. It can provide quality control measure for appraising accuracy of the DIA steps.
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Background
Digital image analysis (DIA) brings great perspectives to
improve reproducibility and capacity of immunohisto-
chemistry (IHC) studies. Nevertheless, the benefits of
reproducibility, capacity and clinical utility are not a
substitute for accuracy or objectivity of the DIA meth-
ods established by comparison to reference data or cri-
terion standard, preferably representing same type of
data obtained by direct and more reliable measurement
[1,2]. While validation studies in digital IHC commonly
relied on pathologists’ visual evaluation or biologic
ground truth (e.g., HER2 FISH [3]) as a criterion stan-
dard, more recently the effort was put into manual
counting of cells to obtain the reference data [4,5].
We have recently reported [6] on methodology to vali-
date and calibrate DIA for Ki67 IHC in breast cancer tis-
sue based on reference data obtained by stereology grid
count performed on the same images: comparison of the
DIA results to the reference data enabled “knowledge-
based” fine-tuning of the DIA settings to achieve better
accuracy. Although the methodology was successful, its
practical application would be time-consuming and
dependent on expert human resource to produce the data.
In the perspective of multiple IHC markers to be analyzed
with variable IHC staining protocols and scanning plat-
forms, the efficiency of continuous quality control and
production of the data sets becomes an important prere-
quisite. This demand has been recognized in broad field of
bio-image informatics with the statement that full-scale
adoption of automated DIA tools would require efficient
production and maintenance of the data sets and provision
of integrated editing tools [7]. The amount of manual
expert work needed on large images with a huge number
of cells is a critical bottle-neck in adoption of the editing-
based approaches [8]. In brain tissue analyses, sophisti-
cated approaches have been proposed to decrease the
workload by calculating a segmentation confidence score
for each cell [9] or identifying potential outliers to priori-
tize the expert review [10].
Clinical adoption of digital IHC techniques could be
synergized by tools enabling efficient production of
reference data sets for divergent IHC applications
requiring proper quality controls. To the best of our
knowledge, editing-based approaches have not been
developed in the field of digital IHC. We therefore pre-
sent a technique (dIHC Wizard) which combines the
swiftness of image processing and the unbiased
approach of stereology and which aims at alleviating
manual workload of the expert in obtaining reference
data sets. DIA is used as an initial step in stereology
grid count procedure to reduce the need for manual
work. The DIA-generated data (dD) are then edited by
an expert to produce the corrected data (cD) which can
be regarded as quality-assured data and be used as the
standard criterion for further DIA calibrations.
Methods
Digital images of Ki67 IHC from 158 female patients
(one millimeter-diameter tissue microarray (TMA) spot
per patient) with an invasive ductal carcinoma of the
breast were used for the study. The study was approved
by the Lithuanian Bioethics Committee. The patients’
consent to participate in the study was obtained. The
TMA were constructed, stained, and scanned as pre-
viously described [11]. Manual data (mD) were obtained
in our previous study [6] by marking Ki67-positive and
negative tumour cell profiles, using a stereological
method for 2D object enumeration [12] implemented in
the Stereology module (ADCIS, France) with a test grid
of systematically sampled frames overlaid on a spot
image in ImageScope (Aperio Technologies, USA).
Automatic image processing was performed using the
combination of the Genie and Nuclear algorithms from
Aperio Technologies (Vista USA) calibrated in the pre-
vious study [6]. The Genie software is used to isolate
the epithelial compartment of the breast carcinoma and
discard stromal and inflammatory components. Nuclear
algorithm allows the refined segmentation of individual
nuclei of cancer cell profiles and the color characteriza-
tion of immunostained and counterstained nuclei. The
dIHC Wizard workflow is presented in the Figure 1.
The dD marks were produced from the multicolor mask
image resulting from the automatic analysis. For this
purpose, an Excess Red Green Blue image was com-
puted (2R-G-B, 2G-R-B and 2B-R-G) and fixed thresh-
olds applied to isolate the automatically labeled
immunostained and counterstained epithelial nuclear
profiles (Figure 2). The dD marks were collected from
the centroid of the labeled nuclear profiles and stored
into an XML file which was then overlaid on the origi-
nal spot images to generate relevant XML tags along
with the stereology grid (Figure 2). This allowed the
expert to edit, by manual adding or deleting, the dD
marks, as needed to produce the cD. The mD and cD
were produced by the same experts. A new file contain-
ing XML tags representing the cD was generated and
compared to the original file (dD) to retrieve data for
statistical analysis (Figure 3). The percentage of Ki67
positive tumour cell profiles per spot (Ki67%) was used
to compare the data sets. True and false positive and
negative Ki67 tumor cell rates as well as lost or false
tumor cells were established for each spot. The mD, dD,
and cD sets were compared by single linear regression
analysis. Agreement between individual measurements
was also estimated and visualized by Bland and Altman
plots [13]. Furthermore, the undetected tumor cells
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were subcategorized to “By the Genie” and “By the
Nuclear” algorithms based on reference of their coordi-
nates to the original DIA markup images. Falsely
detected tumor cells were due to the Genie or the
Nuclear components. This allowed comparing the
impact of the Genie and Nuclear algorithms on dD
error rate providing insights on relative accuracy of each
DIA component. Efficiency of cD production was
Figure 1 dIHC Wizard workflow, the process of the XML tags (Grid and Mark generator) at left and the process of the image analysis
(Genie and Nuclear algorithms and binary mask generator) at right.
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Figure 2 Building of dD marks: Original (initial spot image), Genie (spot image processed by the Genie software), Nuclear (spot image
processed by the Nuclear software in the Genie mask), Excess RGB (computation of an excess red, green and blue image from the Nuclear
resulting image), Negative and Positive (binary masks resulting from Excess RGB image thresholding), Resulting dD (test grid of frames with
marks of the positive, in orange, and negative, in green, nuclear sections).
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Figure 3 Comparison of dD and cD, visual illustration for a spot image (TMA_7_49) and two frames (Frame #41 and Frame #43): red
outline (contour of Genie mask), blue outline (contour of the frame with forbidden line), orange marks (true positive nuclei), yellow marks (false
positives), green marks (true negatives), light blue marks (false negatives), red marks (nuclei falsely detected by Genie or Nuclear software), white
marks (epithelial cell nuclei undetected by Genie software), black marks (epithelial cell nuclei undetected by Nuclear software).
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estimated based on expert editing effort required. Statis-
tical significance level was set at p < 0.05.
Results and discussion
The percentage of Ki67-positive tumor cells in each spot
image (Ki67%) was in a very good agreement in the mD,
dD, and cD sets when compared by single linear regres-
sion analysis (Figure 4). Regression of the cD from the
dD (R2 = 0.92) reflects the impact of the expert editing
the dD as well as accuracy of the DIA used to produce
the dD. Regression of the cD from the mD (R2 = 0.94)
reflects the consistency of the DIA-assisted standard cri-
terion (cD) production with the manually obtained stan-
dard criterion. Slight bias in the opposite directions can
be noted in both comparisons.
Besides the comparison of the summarized TMA
spot indicators in the data sets, our method provides
detailed information on accuracy of detection and the
IHC-positivity interpretation by DIA of individual cells.
Despite the very good agreement of the Ki67% per
spot between the data sets, the accuracy of detection
of individual tumor cells was much lower. Based on
the expert corrections made on the dD to produce the
cD, in average 18 and 219 marks per spot were edited
due to the Genie and Nuclear algorithm errors, respec-
tively (Figure 5); the mean of marks per spot was 663.
In all 158 TMA spots, a total of 105,486 nuclei have
been identified in the cD while 39,710 (37.6%) expert
corrections have been made on the dD, including
2,941 (2.8%) and 24,727 (23.4%) edits to correct the
Genie and Nuclear under-detection of epithelial
nuclear profiles, respectively, and 10,793 (10.2%) over-
detection of epithelial nuclear profiles by Genie or
Nuclear. As described in the Methods section, the
Nuclear component of the DIA was applied only on
the epithelial mask already detected by the Genie com-
ponent, therefore, the performance indicators of the
Nuclear detection component are “Genie-dependent”.
Figure 4 Upwards, comparison between mD and cD by single linear regression analysis at left and Bland Altman analysis at right;
downwards, comparison between dD and cD by single linear regression analysis at left and Bland Altman analysis at right.
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When nucleus is properly identified, the IHC staining
interpretation (Ki67-positive versus negative) by the
Nuclear algorithm can be regarded as excellent: over-
all, only 1,035 (1%) false positive and 214 (0.2%) false
negative tumor nuclei were corrected by the experts
(Figure 6).
Importantly, our data highlight the impact of the accu-
racy definition and the DIA validation results: it was per-
fect with regard to the Ki67% result per image which
could be interpreted as sufficient for clinical use. How-
ever, the accuracy of the individual tumour cell detection
was less satisfactory and may be taken as a warning sign
on the road of developing robust automated DIA tools.
Perhaps, different applications may require more conser-
vative accuracy definitions and validation procedures for
specific DIA tasks.
Furthermore, our approach provided a benefit of
“decomposing” the accuracy of 3 DIA components used by
one expert editing procedure. Importantly, the Genie com-
ponent outperformed the Nuclear algorithm in terms of
tumor cell detection in our experiment. We are not aware
of published data on the relative impact on DIA accuracy
caused by automated tumour (epithelial) tissue and tumour
cell identification components. While the issue of auto-
matic detection and segmentation of cell nuclei in histo-
pathology images is well-addressed, accuracy of tumour
tissue detection would require targeted studies. Lastly, dis-
crimination between the Ki67 IHC staining result (positive
versus negative) by the DIA was excellent in our study.
We therefore suggest that even if the accuracy of the
Ki67% (image-based estimate) on the whole spot series
was very good, more conservative cell-based validation
approach could uncover the “functional anatomy” of the
DIA tools and point further DIA improvement efforts in
the right direction to achieve most robust DIA processes
and results.
The accuracy of the DIA tool used to produce the dD
set determines the efficiency of the DIA-assisted cD
production. In our case, the approach saved approxi-
mately 2/3 of manual editing, however, the effort to
review the images remained the same. The efficiency
can be further increased by improving ergonomics of
the stereology tool and employing a better calibrated
DIA-assistance. In our experiment, we applied systema-
tic random sampling by stereology grid; it is a simple
method to control the amount of manual work, how-
ever, it is subject to variable amount of tumour tissue
and cellularity in the images. This disadvantage can be
compensated by automated resizing of the stereology
grid based on the results of the DIA to produce the dD
set in order to get optimal number of cells to be
reviewed per image.
Last but not least, the mD and/or cD sets are quality-
assured and contain information on exact location of
the cells in the image, therefore, can be utilized as stan-
dard criterion templates to validate, calibrate, and train
DIA tools. On a more global perspective, the reference
data libraries may serve as benchmark datasets for auto-
mated DIA - the demand well-recognized and addressed
in computational neuroscience and bioimage infor-
matics, in general, with tasks of much higher complexity
than the digital IHC [14,15].
Figure 5 Numbers of tumor cell nuclei undetected by the Genie (blue dots) and the Nuclear (orange dots) algorithms.
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Conclusions
We propose the dIHC Wizard to enable image analysis-
assisted stereology approach to produce reference data
in a more efficient way. In our experiment, it reduced
the expert manual work up to 3 times. Importantly, the
tool can also support DIA quality control and improve-
ment efforts since it provides detailed information on
the accuracy of the DIA components applied - tumour
Figure 6 Upwards, the efforts of the experts for correcting undetected (yellow color area) and falsely detected (orange color area)
epithelial cell nuclei and downwards, the efforts for correcting falsely labeled (yellow color area) and unlabeled nuclei (orange color
area) for the whole TMA spot series, presented on the x axis and sorted ascending by the value of the Y axis.
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tissue and tumour cell detection as well as interpretation
of the Ki67 IHC positivity in the detected cells.
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